Patient Guide: A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07160725
Status: NOT_YET_RECRUITING
Condition: Solid Tumours
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Orange, California
  • • Pittsburgh, Pennsylvania
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors - Join Clinical Trial NCTNCT07160725

How to Join This Clinical Trial - NCTNCT07160725

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Solid Tumours. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Solid Tumours. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Solid Tumours
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07160725 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90033 - United States

Status: Contact for availability

Clinical Research Site

Orange, California 92868 - United States

Status: Contact for availability

Clinical Research Site

Pittsburgh, Pennsylvania 15232 - United States

Status: Contact for availability

Clinical Research Site

Sioux Falls, South Dakota 57104 - United States

Status: Contact for availability

Clinical Research Site

Fort Worth, Texas 76104 - United States

Status: Contact for availability

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: Contact for availability

Clinical Research Site

Salt Lake City, Utah 84124 - United States

Status: Contact for availability

Clinical Research Site

Seattle, Washington 98109 - United States

Status: Contact for availability

Clinical Research Site

Copenhagen, Capital Region 2100 - Denmark

Status: Contact for availability

Clinical Research Site

Copenhagen, Capital Region 2730 - Denmark

Status: Contact for availability

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Solid Tumours:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships